background: ectopic pregnancy is one of the main problems in women in reproductive age that needs special attention and appropriate strategy should be managed. in some cases expectant management seems good strategy without any medicine or surgery and their possible side effects. but are the outcomes always the same? which outcomes should we expect? case: we have reported 2 patients whose ectopi...

background: we studied the possible advantages of feed-forward control nursing model in the treatment of placenta previa. methods: we enrolled 60 pregnant women who were receiving treatment for expectant placenta previa between january 2010 and january 2016 and randomly divided them into the control group and the observation group with 30 cases in each group. in the control group, we offered sp...

OBJECTIVE Treatment of fetal macrosomia presents challenges to practitioners because a potential outcome of shoulder dystocia with permanent brachial plexus injury is costly both to families and to society. Practitioner options include labor induction, elective cesarean delivery, or expectant treatment. We performed a cost-effective analysis to evaluate the treatment strategies that were prefer...

BACKGROUND Misoprostol and expectant care have been shown to be acceptable alternatives to routine surgical evacuation for treatment of spontaneous abortion in the first trimester of pregnancy. The objective of this study was to analyse the cost of expectant care, misoprostol therapy and surgical evacuation. METHODS A decision tree was designed to simulate the clinical outcome and health care...

INTRODUCTION Incomplete miscarriage is often treated with surgical evacuation in Sri Lanka. Expectant management, which is an alternative treatment, was assessed for efficacy and safety in a local setting. METHODS Randomised clinical trial of two treatment groups of expectant and surgical management with 71 and 69 participants, respectively, was done at the University Gynaecology Unit of the ...

Intervention: households were allocated to PEP (n = 138 households with 410 HHCs) or expectant treatment (n = 139 households with 402 HHCs). All index patients and HHCs developing illness in the expectant treatment group received oseltamivir treatment (adults and adolescents 75 mg capsules; and children 30–60 mg suspension twice/day) for 5 days. HHCs in the PEP group received the same dosage as...